Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Senseonics Launches Eversense E3 CGM in U.S. - Medical Product Outsourcing

What are you searching for?

Sign in
OEM News

Senseonics Launches Eversense E3 CGM in U.S.

First commercial patient has been implanted with Eversense E3.

Author Image

By: Sam Brusco

Associate Editor

Senseonics and commercialization partner Ascensia Diabetes Care have achieved the first commercial implantation of the Eversense E3 implantable continuous glucose monitor (CGM), marking its launch in the U.S. The Eversense E3 sensor was approved by the U.S. Food and Drug Administration (FDA) in February.
 
“The accuracy, duration and implantable form of Eversense E3 combine to provide diabetes patients confidence and convenience never available previously,” Bantwal S. Baliga, MD: MRCP (U.K.), Director of East Alabama Endocrinology, and the first physician to insert the extended life sensor told the press. “This next-generation implantable system has been designed with patients in mind by offering 6-months of sensor life. It also offers unique benefits like discrete on-body vibratory alerts through a removable transmitter that provides patients wear time flexibility without ever having to waste a sensor. It is an important offering for patients wanting accuracy, protection, and convenience.”
 
According to the company Eversense E3 is the longest lasting CGM available, with a six-month sensor wear time. The fully implantable fluorescence-based sensor has a removable smart transmitter for discreet on-body vibration alerts and data transmission to a mobile app.
 
Eversense E3 also requires fewer calibrations compared to previous Eversense generations.

Add us as a preferred source on Google

Get the latest Medical Product Outsourcing news, insights and analysis in your Google Search and AI experiences.

Add Medical Product Outsourcing as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Medical Product Outsourcing Newsletters

Topics